176 related articles for article (PubMed ID: 21834866)
1. An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection.
Blake E; Allen J; Curnow A
Photochem Photobiol; 2011; 87(6):1419-26. PubMed ID: 21834866
[TBL] [Abstract][Full Text] [Related]
2. The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells.
Blake E; Curnow A
Photochem Photobiol; 2010; 86(5):1154-60. PubMed ID: 20573043
[TBL] [Abstract][Full Text] [Related]
3. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
Blake E; Allen J; Curnow A
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
[TBL] [Abstract][Full Text] [Related]
4. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
5. Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors.
Curnow A; Pye A
J Environ Pathol Toxicol Oncol; 2007; 26(2):89-103. PubMed ID: 17725535
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of delta-aminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells.
Pye A; Curnow A
Photochem Photobiol; 2007; 83(3):766-73. PubMed ID: 17576385
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.
Chang SC; MacRobert AJ; Porter JB; Bown SG
J Photochem Photobiol B; 1997 Apr; 38(2-3):114-22. PubMed ID: 9203372
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma.
Pye A; Campbell S; Curnow A
J Cancer Res Clin Oncol; 2008 Aug; 134(8):841-9. PubMed ID: 18239941
[TBL] [Abstract][Full Text] [Related]
9. The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species.
Dogra Y; Ferguson DCJ; Dodd NJF; Smerdon GR; Curnow A; Winyard PG
Redox Biol; 2016 Oct; 9():90-99. PubMed ID: 27454766
[TBL] [Abstract][Full Text] [Related]
10. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
Magnussen A; Reburn C; Perry A; Wood M; Curnow A
Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
[TBL] [Abstract][Full Text] [Related]
11. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents.
Curnow A; McIlroy BW; Postle-Hacon MJ; Porter JB; MacRobert AJ; Bown SG
Br J Cancer; 1998 Nov; 78(10):1278-82. PubMed ID: 9823966
[TBL] [Abstract][Full Text] [Related]
13. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
14. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
15. Novel Iron-Chelating Prodrug Significantly Enhanced Fluorescence-Mediated Detection of Glioma Cells Experimentally In Vitro.
Reburn C; Gawthorpe G; Perry A; Wood M; Curnow A
Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140009
[TBL] [Abstract][Full Text] [Related]
16. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
18. Topical applications of iron chelators in photosensitization.
Juzeniene A; Juzenas P; Iani V; Moan J
Photochem Photobiol Sci; 2007 Dec; 6(12):1268-74. PubMed ID: 18046481
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol enhances 5-aminolevulinic acid-induced fluorescence and the effect of photodynamic therapy in human glioma.
Chen X; Wang C; Teng L; Liu Y; Chen X; Yang G; Wang L; Liu H; Liu Z; Zhang D; Zhang Y; Guan H; Li X; Fu C; Zhao B; Yin F; Zhao S
Acta Oncol; 2014 Mar; 53(3):405-13. PubMed ID: 24032442
[TBL] [Abstract][Full Text] [Related]
20. Polymeric iron chelators for enhancing 5-aminolevulinic acid-induced photodynamic therapy.
Nomoto T; Komoto K; Nagano T; Ishii T; Guo H; Honda Y; Ogura SI; Ishizuka M; Nishiyama N
Cancer Sci; 2023 Mar; 114(3):1086-1094. PubMed ID: 36341512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]